We’re thrilled to support Gwo-tzer and the Team at The University of Edinburgh in the latest Edinburgh IBD Science study. Overall well-being is an important goal in treating and managing Inflammatory Bowel Disease (IBD). A high proportion of people with IBD feel that their well-being continues to be affected, even Read more…
We have funded multiple studies run by the Exeter IBD and Pharmacogenetics Research Group – headed up by Dr Tariq Ahmad, Consultant Gastroenterologist at the Royal Devon and Exeter. Their work brings hope that personalised medicine is not too far into the future, and we want to help with these Read more…
The work of a Glasgow-based charity has led to a £900,000 donation to a Scots university to continue research on an innovative diet for adults and children with Crohn’s disease. Back in 2017, Cure Crohn’s Colitis invested £50,000 of its funds in the initial open-label trial of CD-TREAT. Now international Read more…
You may remember that we announced our £60,000 investment into the personalised anti-TNF therapy in Crohn’s disease study (PANTS), last year. Although anti-TNF drugs have given new hope for people with Crohn’s Disease and Ulcerative Colitis, and provided an important treatment option, they do not work in some patients. The Read more…
Back in 2017, we announced that we had invested £50,000 in CD-Treat research; a new dietary treatment aimed at combating Crohn’s Disease. Current evidence suggests that a combination of genetics, external influencers and gut microbiota all contribute to the disease activity of Inflammatory Bowel Disease. Studies have shown that disease Read more…
A Luton lad with Crohn’s Disease is giving it a good kicking, as he holds a charity football match to raise awareness about the condition. Read more at Luton Today.
Personalised medicine is a term that has seen a major increase in interest and popularity recently, but I am here to tell you, the potential benefits for IBD patients could be a major game changer! Cure Crohn’s Colitis have invested £60,000 into a project which has the potential to predict an Read more…
Over on the #IBDSuperHeroes blog… UK charity, Cure Crohn’s Colitis has committed £50,000 to CD-Treat, a new dietary treatment aimed at combating Crohn’s Disease. Inflammatory Bowel Disease (IBD) is a debilitating, and so far, incurable disease of the gastrointestinal tract. Symptoms include, but are not limited to, pain where the disease is Read more…
An East Ren-based charity is helping to fund an innovative research project to help sufferers of Crohn’s disease. Cure Crohn’s and Colitis, whose chair is Newton Mearns lawyer Roy Provan, has donated £50,000 towards “CD-TREAT” a new dietary treatment aimed at combating the inflammatory bowel disease (IBD). It is hoped Read more…
This World IBD day, and every other day of the year, IBD Superheroes around the globe are fighting hard to cure Inflammatory Bowel Disease. Read more on Huffington Post.